切换至 "中华医学电子期刊资源库"

中华腔镜泌尿外科杂志(电子版) ›› 2023, Vol. 17 ›› Issue (06) : 611 -615. doi: 10.3877/cma.j.issn.1674-3253.2023.06.013

临床研究

上尿路结石内镜手术后尿源性脓毒血症病原菌耐药及死亡高危因素分析
王晓丹, 王媛, 崔向宇, 任晓磊()   
  1. 024000 内蒙古自治区,赤峰学院附属医院泌尿外科(赤峰学院泌尿外科研究所)
    024000 内蒙古自治区,赤峰学院附属医院检验科
  • 收稿日期:2022-07-22 出版日期:2023-12-01
  • 通信作者: 任晓磊
  • 基金资助:
    内蒙古自治区卫健委医疗卫生科技计划项目(202201551)

Analysis of pathogenic bacteria resistance of drug and high risk factors of death in urogenic sepsis after endoscopic surgery for upper urinary tract stones

Xiaodan Wang, Yuan Wang, Xiangyu Cui, Xiaolei Ren()   

  1. Department of Urology, the Affiliated Hospital of Chifeng University (Institute of Urology, Chifeng University), Inner Mongolia Autonomous Region 024000, China
    Department of Laboratory, the Affiliated Hospital of Chifeng University, Inner Mongolia Autonomous Region 024000, China
  • Received:2022-07-22 Published:2023-12-01
  • Corresponding author: Xiaolei Ren
引用本文:

王晓丹, 王媛, 崔向宇, 任晓磊. 上尿路结石内镜手术后尿源性脓毒血症病原菌耐药及死亡高危因素分析[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(06): 611-615.

Xiaodan Wang, Yuan Wang, Xiangyu Cui, Xiaolei Ren. Analysis of pathogenic bacteria resistance of drug and high risk factors of death in urogenic sepsis after endoscopic surgery for upper urinary tract stones[J/OL]. Chinese Journal of Endourology(Electronic Edition), 2023, 17(06): 611-615.

目的

分析上尿路结石内镜术后尿源性脓毒血症病原菌耐药特点及死亡的高危因素。

方法

回顾性分析2016年1月至2022年1月在赤峰学院附属医院采用内镜治疗的108例上尿路结石且术后发生尿源性脓毒血症患者的临床资料,根据预后分为死亡组及治愈组,分析其病原菌耐药性特点,同时采用多因素非条件Logistic回归模型从术前相关因素、手术相关因素、转入ICU后相关因素及病原菌相关因素四个方面分析上尿路结石内镜术后尿源性脓毒血症死亡的高危因素。

结果

死亡组和治愈组患者分别为21及87例。共培养出108株菌株,其中革兰氏阴性菌85株(78.70%)、革兰氏阳性菌21株(19.44%)、真菌2株(1.85%)。革兰氏阴性菌中排在前三位的依次为大肠埃希菌、粘质沙雷氏菌及铜绿假单胞菌,革兰氏阳性菌中前三位分别为粪肠球菌、屎肠球菌及金黄色葡萄球菌,真菌包括热带假丝酵母菌和白色假丝酵母菌。革兰氏阴性菌中产超广谱β-内酰胺酶(ESBLs)菌检出16株,革兰氏阳性菌中耐甲氧西林金黄色葡萄球菌(MRSA)检出4株。革兰氏阴性菌中,大肠埃希菌对头孢呋辛耐药率为88.57%,粘质沙雷菌对头孢呋辛及头孢噻肟耐药率最高均为83.33%,铜绿假单胞菌对左旋氧氟沙星耐药率为44.44%,革兰氏阳性菌对红霉素耐药率最高为100%。单因素分析结果显示,女性、糖尿病、自身免疫病、术前尿细菌培养阳性、手术时间、患者急性生理与慢性健康状况(APACHE II)评分、序贯器官衰竭(SOFA)评分及产ESBLs菌是上尿路结石术后尿源性脓毒血症死亡的相关因素,差异均有统计学意义(P<0.05),Logistic回归分析显示女性、糖尿病、自身免疫病、APACHE II评分、SOFA评分及产ESBLs菌是死亡的独立危险因素。

结论

上尿路结石内镜术后尿源性脓毒血症病原菌以革兰氏阴性菌为主且耐药率较高,女性、糖尿病、自身免疫病、APACHE II评分、SOFA评分及产ESBLs菌是该类患者死亡的高危因素。

Objective

To analyze the characteristics of drug resistance and high risk factors of death of pathogenic bacteria of urogenic sepsis after endoscopic surgery for upper urinary tract calculi.

Methods

The clinical data of 108 patients with upper urinary tract calculi treated by endoscopy in the Affiliated Hospital of Chifeng University from January 2016 to January 2022 were analyzed retrospectively. They were divided into death group and cure group according to the prognosis. The characteristics of pathogen drug resistance were analyzed. At the same time, multivariate unconditional logistic regression model was used to analyze the high-risk factors of urogenic sepsis death after endoscopic surgery for upper urinary calculi, which was analyzed from four aspects: preoperative, surgical, ICU and pathogen related factors.

Results

There were 21 patients in death group and 87 in the cure group. 108 strains were cultured, including 85 strains of gram-negative bacteria (78.70%), 21 strains of gram-positive bacteria (19.44%) and 2 strains of fungi (1.85%). The top three gram-negative bacteria were Escherichia coli, Serratia marcescens and Pseudomonas aeruginosa. The top three gram-positive bacteria were Enterococcus faecalis, Enterococcus faecium and Staphylococcus aureus. The fungi included Candida tropicalis and Candida albicans. 16 strains of extended-spectrum β lactamases (ESBLs) producing bacteria were detected in gram-negative bacteria, and 4 strains of Methicillin-resistant Staphylococcus aureus (MRSA) were detected in gram-positive bacteria. Among gram-negative bacteria, the drug resistance rate of Escherichia coli to Cefuroxime was 88.57%, the drug resistance rate of Serratia marcescens to Cefuroxime and Cefotaxime was 83.33%, the drug resistance rate of Pseudomonas aeruginosa to Levofloxacin was 44.44%, and the drug resistance rate of gram-positive bacteria to Erythromycin was 100%. Univariate analysis showed that female, diabetes, autoimmune diseases, preoperative bacterial positive urine, operation time, acute physiology and chronic health status (APACHE II) score, sequential organ failure assessment (SOFA) score and ESBLs producing bacteria were the related factors of death after urinary calculi surgery (P<0.05). Multivariate logistic regression analysis showed that female, diabetes, autoimmune disease, APACHE II score, SOFA score and ESBLs producing bacteria were independent risk factors for death.

Conclusions

Gram-negative bacteria are the main pathogens of urinary tract sepsis after endoscopic surgery for upper urinary tract calculi and the resistance rate is high. Female, diabetes, autoimmune diseases, APACHE II score, SOFA score and ESBLs producing bacteria are risk factors for death.

表1 尿源性脓毒血症患者病原菌血培养情况
表2 所分离的主要革兰氏阴性菌对常用抗菌药物的耐药率[例(%)]
表3 所分离的主要革兰氏阳性菌对常用抗菌药物的耐药率[例(%)]
表4 尿源性脓毒血症死亡单因素分析
表5 尿源性脓毒血症患者死亡多因素Logistic回归分析
[1]
Marangella M. Medical management of urinary calculi: up to date 2016[J]. Urologia, 2016, 83(3):110-123.
[2]
储传敏,张鹤,王磊,等. 2019年泌尿系统结石诊治进展[J]. 上海医学, 2020, 43(6): 341-346.
[3]
Chugh S, Pietropaolo A, Montanari E, et al. Predictors of urinary infections and urosepsis after ureteroscopy for stone disease: a systematic review from EAU Section of Urolithiasis (EULIS)[J]. Curr Urol Rep, 2020, 21(4):16.
[4]
任晓磊,夏海波. 泌尿系结石腔镜手术后尿源性脓毒血症发生的原因及防治[J/CD]. 中华腔镜泌尿外科杂志(电子版), 2018, 12(5): 356-358.
[5]
Bonkat G, Cai T, Veeratterapillay R, et al. Management of urosepsis in 2018[J]. Eur Urol Focus, 2019, 5(1): 5-9.
[6]
Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021[J]. Crit Care Med, 2021, 49(11): e1063-e1143.
[7]
杜建辉,向芹,杨振琪,等. 经皮肾镜碎石术后患者尿源性脓毒血症的影响因素分析[J]. 国际泌尿系统杂志, 2021, 41(1): 49-52.
[8]
齐士勇,王琦,王兴羽,等. 两种肾盂减压方式治疗上尿路结石合并尿源性脓毒血症的效果比较[J]. 中华泌尿外科杂志, 2020, 41(4): 256-261.
[9]
范永保,沈文,吴义高,等. 输尿管结石微创术后感染性发热危险因素分析[J]. 临床泌尿外科杂志, 2021, 36(11): 897-899.
[10]
刘万樟,严泽军,程跃. 经皮肾镜术中肾盂压力影响因素研究进展[J]. 现代泌尿外科杂志, 2020, 25(5): 457-459;457-459, 461.
[11]
史新莉,沈俊文. 输尿管软镜下钬激光碎石取石术后患者并发尿脓毒血症的影响因素分析[J]. 中国现代医生, 2021, 59(23): 52-55.
[12]
Kallidonis P, Panagopoulos V, Kyriazis I, et al. Complications of percutaneous nephrolithotomy: classification, management, and prevention[J]. Curr Opin Urol, 2016, 26(1): 88-94.
[13]
孙玉勤,范沛,榕郝志. 泌尿系统腔镜碎石取石术后尿源性脓毒血症预警评估指标体系的构建[J]. 护理研究, 2021, 35(16): 2987-2990.
[14]
Levy MM, Artigas A, Phillips GS, et al. Outcomes of the surviving sepsis campaign in intensive care units in the USA and Europe: a prospective cohort study[J]. Lancet Infect Dis, 2012, 12(12): 919-924.
[15]
邹雄,陈悟文,廖国涛. 输尿管软镜碎石术后尿源性脓毒血症的防治[J]. 中华腔镜泌尿外科杂志(电子版), 2020, 14(3): 238-240.
[16]
张海民,彭波,王光春,等. 早期持续性肾脏替代治疗对尿源性脓毒血症预后的影响[J]. 中华泌尿外科杂志, 2018, 39(Z1): 50-53.
[17]
叶俊兵. 泌尿系结石合并感染的病原菌分布特点及药敏分析[D].辽宁: 中国医科大学, 2022.
[18]
何源. 泌尿外科447例尿源性脓毒血症病原菌群分布及药敏性分析[D]. 广西: 广西医科大学, 2019.
[19]
马占一,李传贵,张敬红,等. CRP、PCT、NLR联合检测预警输尿管结石发生尿源性脓毒血症的临床研究[J]. 陆军军医大学学报, 2022, 44(6): 589-594.
[20]
潘红,沈俊文,王荣江. 术前尿培养、术中肾盂尿培养对于输尿管软镜术后发生尿源性脓毒血症的诊断价值[J]. 中国卫生检验杂志. 2021, 31(2): 183-186;183-186, 190.
[1] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[2] 莫淇舟, 苏劲, 黄健, 李健维, 李思宁, 柳建军. 智能控压输尿管软镜碎石吸引取石术在直径10~25 mm上尿路结石中的应用[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 497-502.
[3] 邢嘉翌, 龚佳晟, 祝佳佳, 陆群. 肺癌化疗患者继发肺部感染的病原菌耐药性及炎症因子变化分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 714-718.
[4] 杨慧, 郭丽娟, 冯晓丹, 李静, 黄成谋, 蔡兴锐, 覃英娇, 王远礼. 非小细胞肺癌铂类药物耐药mi RNA表达特征及预测分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 719-724.
[5] 刘春军, 严方方, 王宝锋, 常婷婷, 郭红红, 李志强. 替加环素联合人免疫球蛋白治疗XDRAB致VAP 的疗效分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 797-800.
[6] 中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[7] 陈伟杰, 何小东. 胆囊癌免疫靶向治疗进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 763-768.
[8] 林科灿, 罗柳平. 肝胰十二指肠切除术在胆囊癌和胆管癌应用中的关键问题[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 774-778.
[9] 张英信, 林婷, 张剑文. 构建靶向HLA-A2且表达PD-L1的CAR-Treg细胞及验证其对CD4+T细胞抑制作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 719-728.
[10] 张少青, 吕玉风, 董海霞. 中性粒细胞百分比/白蛋白比值对维持性血液透析患者全因死亡的预测作用[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 321-326.
[11] 王涛, 刘静, 高玉伟, 王兴华, 胡秀红, 崔红蕊, 徐保振, 杨洪娟. 抗生素耐药背景下中医药防治腹膜透析相关性腹膜炎研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 340-344.
[12] 王如海, 王绅, 张敏, 李春, 韩超, 于强, 胡海成, 李习珍. 重型创伤性脑损伤患者去骨瓣减压术后短期死亡风险的影响因素分析[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(05): 285-291.
[13] 颜世锐, 熊辉. 感染性心内膜炎合并急性肾损伤患者的危险因素探索及死亡风险预测[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 618-624.
[14] 丁洪基, 赵长江, 孙鹏飞, 王灿, 王贵珍, 李龙龙. 细胞焦亡与疾病的关系研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 682-686.
[15] 徐靖亭, 孔璐. PARP抑制剂治疗卵巢癌的耐药机制及应对策略[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 584-588.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?